FLINT, MI
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)GENESYS HURLEY CANCER INSTITUTE, founded in 2001, is a community nonprofit in the Health Care sector that reported $8.7M in total revenue in fiscal year 2022. Revenue decreased 15% compared to the prior year.
PROVIDE HIGHEST QUALITY OF CANCER CARE ON PATIENT CLINICAL NEEDS, RESEARCH, QUALITY OF LIFE AND HOPE FOR THE FUTURE.
FOR THE TWELVE MONTHS ENDED JUNE 30, 2023, THERE WERE 769 PATIENTS SEEN AT THE GENESYS HURLEY CANCER INSTITUTE. THERE WERE APPROXIMATELY 11,648 TREATMENTS FOR THE YEAR, INCLUDING 7,133 IMRT AND 4,008...
FOR THE TWELVE MONTHS ENDED JUNE 30, 2023, THERE WERE 769 PATIENTS SEEN AT THE GENESYS HURLEY CANCER INSTITUTE. THERE WERE APPROXIMATELY 11,648 TREATMENTS FOR THE YEAR, INCLUDING 7,133 IMRT AND 4,008 NON-IMRT TREATMENTS.ADDITIONAL PATIENT SERVICES INCLUDE 1,070 NUTRITION CONSULTS, 175 PATIENTS ENROLLED IN RESEARCH STUDIES, OVER 200 PATIENT AND CAREGIVER QUALITY OF LIFE PROGRAMS OFFERED WITH OVER 2,400 ATTENDEES, AND 3,019 RIDES WERE PROVIDED TO OVER 400 PATIENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $8,696,619 | $10,186,587 | -0.1% |
| Expenses | $8,777,518 | $8,877,300 | 0.0% |
| Net Income | $-80,899 | $1,309,287 | -1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MICHAEL BURNETT | CHAIR (THRU 03/2023) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KEITH PONIERS | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOHN STEWART | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| NANCY HAYWOOD | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| REBECCA BANAT | SECRETARY (THRU 08/2022) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| CHARLOTTE EDWARDS | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KATHI SMITH-NOWLIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOANNE HERMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DR WILLIAM EDGAR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DR PUNAM SHARMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BARRY FAGAN | INTERIM EXEC. DIRECTOR | 40.00 |
Officer
|
$103,336 | $65,763 | $169,099 |
| IBRAHIM ABDULHAY | PHYSICIST | 40.00 |
Highest
|
$239,765 | $15,238 | $255,003 |
| LESLIE BOULAY | PHYSICIST | 40.00 |
Highest
|
$193,308 | $14,360 | $207,668 |
| ERIC KEDROSKE | DOSIMETRIST | 40.00 |
Highest
|
$170,438 | $10,725 | $181,163 |
| KENDALL SMITH | DOSIMETRIST | 40.00 |
Highest
|
$152,540 | $11,821 | $164,361 |
| MELISSA FARNEY | QUALITY MANAGER | 40.00 |
Highest
|
$102,500 | $17,800 | $120,300 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $8,696,619 | $8,777,518 | $17,712,427 | $-80,899 |
| 2022 | $10,186,587 | $8,877,300 | $17,853,805 | $1,309,287 |
| 2021 | $9,131,545 | $8,841,208 | $18,530,778 | $290,337 |
| 2020 | $8,925,137 | $9,193,899 | $18,694,952 | $-268,762 |
| 2019 | $9,137,186 | $8,605,554 | $19,550,788 | $531,632 |
| 2018 | $7,960,833 | $7,713,583 | $18,967,094 | $247,250 |
Compare GENESYS HURLEY CANCER INSTITUTE with other nonprofits in Michigan and across the country.